Accessibility Menu
 
Q32 Bio logo

Q32 Bio

(NASDAQ) QTTB

Current Price$5.90
Market Cap$106.06M
Since IPO (2024)-65%
5 Year-97%
1 Year+245%
1 Month+29%

Q32 Bio Financials at a Glance

Market Cap

$106.06M

Revenue (TTM)

$53.74M

Net Income (TTM)

$29.82M

EPS (TTM)

$2.30

P/E Ratio

3.15

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Price

$5.90

Volume

593,773.718

Open

$7.01

Previous Close

$5.90

Daily Range

$5.66 - $7.49

52-Week Range

$1.34 - $8.04

QTTB News

QTTB: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Q32 Bio

Industry

Biotechnology

Employees

24

CEO

Jodie P. Morrison

Headquarters

Waltham, MA 02451, US

QTTB Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

31%

Net Income Margin

55%

Return on Equity

125%

Return on Capital

34%

Return on Assets

48%

Earnings Yield

31.75%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$106.06M

Shares Outstanding

14.63M

Volume

593.77K

Short Interest

0.00%

Avg. Volume

212.14K

Financials (TTM)

Gross Profit

$53.35M

Operating Income

$16.90M

EBITDA

$17.29M

Operating Cash Flow

$24.19M

Capital Expenditure

$2.00K

Free Cash Flow

$24.18M

Cash & ST Invst.

$48.30M

Total Debt

$15.34M

Q32 Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$53.74M

N/A

Gross Profit

$53.65M

+44805.8%

Gross Margin

99.83%

N/A

Market Cap

$106.06M

N/A

Market Cap/Employee

$3.79M

N/A

Employees

28

N/A

Net Income

$57.73M

+506.9%

EBITDA

$45.88M

+583.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$37.12M

-37.2%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$4.94M

-67.5%

Short Term Debt

$6.24M

+68.1%

Return on Assets

48.27%

N/A

Return on Invested Capital

33.52%

N/A

Free Cash Flow

$6.18M

+45.9%

Operating Cash Flow

$6.18M

+45.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANTXAN2 Therapeutics, Inc.
$3.46-5.46%
VRCAVerrica Pharmaceuticals Inc.
$4.76+8.68%
SABSSAB Biotherapeutics, Inc.
$3.78-1.82%
GBIOGeneration Bio Co.
$5.34+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.52+0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$37.89-0.02%
QQQInvesco QQQ Trust
$558.28-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.13-0.04%

Questions About QTTB

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.